VPAG

News

UK is becoming an 'outlier' for pharma, hitting investment

UK pharma leaders have renewed calls for a rethink by the government on levies imposed on medicine sales, saying investment is already being hit.

Market Access

blue and white medication capsule tablets

NHS medicines spending in England in greater focus

Leela Barham provides a perspective on the ABPI blog that covers understanding NHS medicines spending in England.

News

Pharma furious as UK Statutory Scheme rebate rate soars

The UK pharma sector has reacted with consternation to the government's proposal to raise the Statutory Scheme rate to 32.2% in the last half of 2025.

News

Pharma urges NHS to put medicines at heart of 10-year plan

The UK pharma industry has warned that declining access to new medicines in England will undermine the government's efforts to rebuild the NHS.

News

Woman in protective clothing in a laboratory

Report says AZ's UK plant decision is not just about funding

It's been reported that the UK government made an offer of £78 million in funding for AstraZeneca's abandoned £450 million vaccine facility in Speke.

Market Access

Metrics for the UK’s VPAG: A work in progress

Just as for previous schemes, metrics are being used to track VPAG, the UK’s voluntary scheme that covers branded medicines pricing and access.

UK is becoming an 'outlier' for pharma, hitting investment

NHS medicines spending in England in greater focus

Pharma furious as UK Statutory Scheme rebate rate soars

Pharma urges NHS to put medicines at heart of 10-year plan

Report says AZ's UK plant decision is not just about funding

Metrics for the UK’s VPAG: A work in progress

Lundbeck preps for key bexicaserin data around year-end

Discover a new era of healthcare panel engagement: Grounded ...

VPAG

Editor's Picks